1. Home
  2. ABEO vs COOK Comparison

ABEO vs COOK Comparison

Compare ABEO & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • COOK
  • Stock Information
  • Founded
  • ABEO 1974
  • COOK 1985
  • Country
  • ABEO United States
  • COOK United States
  • Employees
  • ABEO N/A
  • COOK N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • COOK Wholesale Distributors
  • Sector
  • ABEO Health Care
  • COOK Consumer Discretionary
  • Exchange
  • ABEO Nasdaq
  • COOK Nasdaq
  • Market Cap
  • ABEO 256.9M
  • COOK 255.1M
  • IPO Year
  • ABEO 1980
  • COOK 2021
  • Fundamental
  • Price
  • ABEO $5.57
  • COOK $1.75
  • Analyst Decision
  • ABEO Strong Buy
  • COOK Buy
  • Analyst Count
  • ABEO 6
  • COOK 7
  • Target Price
  • ABEO $18.00
  • COOK $2.43
  • AVG Volume (30 Days)
  • ABEO 1.1M
  • COOK 787.2K
  • Earning Date
  • ABEO 08-11-2025
  • COOK 08-05-2025
  • Dividend Yield
  • ABEO N/A
  • COOK N/A
  • EPS Growth
  • ABEO N/A
  • COOK N/A
  • EPS
  • ABEO N/A
  • COOK N/A
  • Revenue
  • ABEO N/A
  • COOK $602,441,000.00
  • Revenue This Year
  • ABEO N/A
  • COOK $0.06
  • Revenue Next Year
  • ABEO $323.51
  • COOK $3.18
  • P/E Ratio
  • ABEO N/A
  • COOK N/A
  • Revenue Growth
  • ABEO N/A
  • COOK 0.80
  • 52 Week Low
  • ABEO $3.93
  • COOK $1.28
  • 52 Week High
  • ABEO $7.32
  • COOK $3.97
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 37.51
  • COOK 51.18
  • Support Level
  • ABEO $5.66
  • COOK $1.67
  • Resistance Level
  • ABEO $6.24
  • COOK $1.88
  • Average True Range (ATR)
  • ABEO 0.26
  • COOK 0.12
  • MACD
  • ABEO -0.08
  • COOK -0.02
  • Stochastic Oscillator
  • ABEO 8.08
  • COOK 7.84

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

Share on Social Networks: